Education
About Us
Working with TipRanks
Follow Us
Evogene (EVGN)
NASDAQ:EVGN
Total Valuation
Evogene has a market cap or net worth of $9.15M. The enterprise value is $6.83M.
Market Cap$9.15M
Enterprise Value$6.83M
Share Statistics
Evogene has 8,718,193 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,718,193
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Evogene’s return on equity (ROE) is 11.36 and return on invested capital (ROIC) is -67.65%.
Return on Equity (ROE)11.36
Return on Assets (ROA)-0.41
Return on Invested Capital (ROIC)-67.65%
Return on Capital Employed (ROCE)-1.03
Revenue Per Employee72.74K
Profits Per Employee-154.31K
Employee Count117
Asset Turnover0.21
Inventory Turnover2.82
Valuation Ratios
The current PE Ratio of Evogene is ―. Evogene’s PEG ratio is 0.01.
PE Ratio―
PS Ratio1.25
PB Ratio-7.34
Price to Fair Value-7.34
Price to FCF-0.52
Price to Operating Cash Flow-0.46
PEG Ratio0.01
Income Statement
In the last 12 months, Evogene had revenue of 8.51M and earned -16.48M in profits. Earnings per share was -2.89.
Revenue8.51M
Gross Profit3.39M
Operating Income-21.73M
Pretax Income-18.05M
Net Income-16.48M
EBITDA-15.38M
Earnings Per Share (EPS)-2.89
Cash Flow
In the last 12 months, operating cash flow was -16.48M and capital expenditures -457.29K, giving a free cash flow of -16.94M billion.
Operating Cash Flow-16.48M
Free Cash Flow-16.94M
Free Cash Flow per Share-1.94
Dividends & Yields
Evogene pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.74
52-Week Price Change-41.99%
50-Day Moving Average1.10
200-Day Moving Average1.21
Relative Strength Index (RSI)46.25
Average Volume (3m)115.16K
Important Dates
Evogene upcoming earnings date is Mar 5, 2026, TBA (Confirmed).
Last Earnings DateNov 20, 2025
Next Earnings DateMar 5, 2026
Ex-Dividend Date―
Financial Position
Evogene as a current ratio of 1.15, with Debt / Equity ratio of -357.32%
Current Ratio1.15
Quick Ratio1.06
Debt to Market Cap0.97
Net Debt to EBITDA0.16
Interest Coverage Ratio-175.27
Taxes
In the past 12 months, Evogene has paid 9.00K in taxes.
Income Tax9.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Evogene EV to EBITDA ratio is -0.53, with an EV/FCF ratio of -0.40.
EV to Sales0.97
EV to EBITDA-0.53
EV to Free Cash Flow-0.40
EV to Operating Cash Flow-0.42
Balance Sheet
Evogene has $15.96M in cash and marketable securities with $2.52M in debt, giving a net cash position of $13.44M billion.
Cash & Marketable Securities$15.96M
Total Debt$2.52M
Net Cash$13.44M
Net Cash Per Share$1.54
Tangible Book Value Per Share$0.46
Margins
Gross margin is 46.76%, with operating margin of -255.36%, and net profit margin of -193.69%.
Gross Margin46.76%
Operating Margin-255.36%
Pretax Margin-212.02%
Net Profit Margin-193.69%
EBITDA Margin-180.68%
EBIT Margin-210.10%
Analyst Forecast
The average price target for Evogene is $2.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.50
Price Target Upside127.27% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-29.78%
EPS Growth Forecast88.96%